Parexel International Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Parexel International Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11520
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Parexel International Corp (Parexel) is a biopharmaceutical outsourcing service company which focuses on providing various services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of services including clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, regulatory and product development and commercialization consulting among several others. Parexel caters its products and services to pharmaceutical, biotechnology and medical device industries worldwide. The company offers its services through a network of offices in various countries across the world. Parexel is headquartered in Waltham, Massachusetts, the US.

Parexel International Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Parexel International Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Parexel International Corp, Medical Devices Deals, 2012 to YTD 2018 10
Parexel International Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Parexel International Corp, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
Pamplona Capital Management Acquires Parexel International for USD5 Billion 12
Partnerships 14
Parexel Enters into Agreement with Microsoft 14
Parexel Enters into Agreement with Osaka International Cancer 15
InDex Pharma Enters into Agreement with Parexel 16
Polus Enters into Agreement with Parexel 17
Parexel International Enters Into Agreement With National Taiwan University Hospital 18
Debt Offering 19
Parexel International Completes Private Placement Of Notes Due 2020 For US$100 Million 19
Acquisition 20
Parexel International Acquires Medical Affairs Company 20
Parexel International Acquires Quantum Solutions, Contract Research Organization 21
Parexel Acquires ClinIntel 22
Parexel International Acquires Atlas Medical 23
Parexel Acquires Heron Group For USD37 Million 24
Parexel International Acquires Liquent For USD74.3 Million 25
Parexel International Corp – Key Competitors 26
Parexel International Corp – Key Employees 27
Parexel International Corp – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 33
Financial Announcements 33
Aug 28, 2017: PAREXEL International Reports Fourth Quarter and Fiscal Year 2017 Results 33
May 03, 2017: PAREXEL International Reports Third Quarter Fiscal Year 2017 Results 34
Feb 01, 2017: PAREXEL International Reports Second Quarter Fiscal Year 2017 Results 36
Corporate Communications 38
Nov 12, 2018: Parexel announces appointment of new members to its Board of Directors 38
Aug 16, 2018: PAREXEL announces appointment of two key executives 40
Apr 25, 2018: PAREXEL Names Peyton Howell as Chief Commercial and Strategy Officer 41
Mar 05, 2018: PAREXEL Names Jamie Macdonald As Chief Executive Officer 42
Feb 28, 2017: PAREXEL International Appoints Simon Harford as Senior Vice President and Chief Financial Officer 43
Government and Public Interest 44
May 15, 2018: CRO Industry Update: Big Data Drives Drug Development Efforts 44
Other Significant Developments 47
Oct 31, 2018: PAREXEL navigates China’s complex drug development and market landscape for global biopharmaceutical companies with new China Advisory Service 47
Sep 11, 2018: PAREXEL advances patient-centric drug development with introduction of its patient innovation center 48
Mar 21, 2018: PAREXEL Introduces Integrated Medical Writing Solutions Service Offering 49
Feb 12, 2018: PAREXEL Introduces Biological Sample Lifecycle Management Service to Address Growing Demand Across Drug Development 50
Sep 06, 2017: PAREXEL Launches Real-World Data Service Offering to Drive Value Demonstration of New Treatments 51
Jun 19, 2017: PAREXEL Introduces Its Connected Journey of Newly Integrated Data-Driven Services to Simplify Drug Development and Commercialization 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53

List of Tables
Parexel International Corp, Pharmaceuticals & Healthcare, Key Facts 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Parexel International Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Parexel International Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Parexel International Corp, Medical Devices Deals, 2012 to YTD 2018 10
Parexel International Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Pamplona Capital Management Acquires Parexel International for USD5 Billion 12
Parexel Enters into Agreement with Microsoft 14
Parexel Enters into Agreement with Osaka International Cancer 15
InDex Pharma Enters into Agreement with Parexel 16
Polus Enters into Agreement with Parexel 17
Parexel International Enters Into Agreement With National Taiwan University Hospital 18
Parexel International Completes Private Placement Of Notes Due 2020 For US$100 Million 19
Parexel International Acquires Medical Affairs Company 20
Parexel International Acquires Quantum Solutions, Contract Research Organization 21
Parexel Acquires ClinIntel 22
Parexel International Acquires Atlas Medical 23
Parexel Acquires Heron Group For USD37 Million 24
Parexel International Acquires Liquent For USD74.3 Million 25
Parexel International Corp, Key Competitors 26
Parexel International Corp, Key Employees 27
Parexel International Corp, Other Locations 28
Parexel International Corp, Subsidiaries 29

List of Figures
Parexel International Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Parexel International Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Parexel International Corp, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Parexel International Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Byco Petroleum Pakistan Ltd (BYCO):企業の財務・戦略的SWOT分析
    Byco Petroleum Pakistan Ltd (BYCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Taiwan High Speed Rail Corporation:企業の戦略・SWOT・財務情報
    Taiwan High Speed Rail Corporation - Strategy, SWOT and Corporate Finance Report Summary Taiwan High Speed Rail Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Engepack Embalagens Sa:企業の戦略・SWOT・財務分析
    Engepack Embalagens Sa - Strategy, SWOT and Corporate Finance Report Summary Engepack Embalagens Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • COWI AS:企業の戦略的SWOT分析
    COWI AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Hydro One Ltd (H):電力:M&Aディール及び事業提携情報
    Summary Hydro One Ltd (Hydro One) is a utility holding company that conducts electricity transmission and distribution in Ontario through its subsidiaries. It also undertakes telecommunications business and certain corporate activities. The company serves residential, commercial and industrial custo …
  • Delta Electricity:企業の戦略的SWOT分析
    Delta Electricity - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Callaway Golf Company (ELY):企業の財務・戦略的SWOT分析
    Callaway Golf Company (ELY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • ERG SpA (ERG):企業の財務・戦略的SWOT分析
    ERG SpA (ERG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Medical & Biological Laboratories Co Ltd (4557)-医療機器分野:企業M&A・提携分析
    Summary Medical & Biological Laboratories Co Ltd (MBL) is a provider of clinical and basic laboratory diagnostics. The company’s products comprise research reagents, diagnostic reagents and companion diagnostics. It provides diagnostic reagents for therapeutic areas of allergy, antiphospholipid synd …
  • National Company KazMunayGas:企業の戦略的SWOT分析
    National Company KazMunayGas - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Reitmans (Canada) Limited (RET.A):企業の財務・戦略的SWOT分析
    Reitmans (Canada) Limited (RET.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • OAO Tatneft:企業の戦略・SWOT・財務情報
    OAO Tatneft - Strategy, SWOT and Corporate Finance Report Summary OAO Tatneft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Korea National Oil Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Korea National Oil Corp (KNOC) is a state-owned integrated oil company that carries out the exploration, development and production of oil and gas, and stockpiling of petroleum resources. The company purchases and sells crude oil, distribute gasoline and refined products. It also imports and …
  • Complexa Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Complexa Inc (Complexa) is a biopharmaceutical company that develops endogenous human cell signalling treatments for fibrosis and inflammation related diseases. The company’s lead product candidate products includes CXA-10 is an endogenous nitro fatty acid that modulates the human body’s mai …
  • Anthem Inc (ANTM):企業の財務・戦略的SWOT分析
    Anthem Inc (ANTM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Align Technology, Inc.:企業の戦略・SWOT・財務情報
    Align Technology, Inc. - Strategy, SWOT and Corporate Finance Report Summary Align Technology, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Anchor Glass Container Corp.:企業の戦略・SWOT・財務情報
    Anchor Glass Container Corp. - Strategy, SWOT and Corporate Finance Report Summary Anchor Glass Container Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Span-America Medical Systems Inc (SPAN):企業の財務・戦略的SWOT分析
    Summary Span-America Medical Systems Inc (Span-America), a subsidiary of Savaria Corp, is a medical device company that designs and manufactures pressure management and patient positioning products. The company offers products such as surfaces, seat cushions, patient positioners, skin care products, …
  • Relisys Medical Devices Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Relisys Medical Devices Ltd (Relisys), formerly Care Polymed Ltd is a medical device company that develops, manufactures and commercializes catheter products. The company’s products include drug eluting stent systems, bare metal stent systems, PTCA catheters and angiographic catheters. Its a …
  • EDF Energy Holdings Ltd:企業の戦略的SWOT分析
    EDF Energy Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆